← Back to home

Novo Nordisk Says CagriSema Was Tied to 25% Average Weight Loss in Women in a Trial Analysis

Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources

Brief

Novo said Tuesday that its experimental weekly injection CagriSema was associated with an average weight loss…

Keep reading with NewsPlain Premium

Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.

2 sources behind this story.

About this story

We haven’t published a correction to this story.

How NewsPlain works
← Back to home